Your prediction
Fresenius SE & Co. KGaA ADR Stock
Fresenius SE & Co. KGaA ADR dominated the market today, gaining €0.80 (7.080%).
Pros and Cons of Fresenius SE & Co. KGaA ADR in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius SE & Co. KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA ADR | 7.080% | 4.310% | 18.627% | 16.346% | 2.542% | 70.423% | 8.036% |
| Fresenius SE & Co. KGaA | 0.040% | 4.511% | 10.373% | 7.325% | -3.824% | 58.244% | 4.441% |
| Fresenius Medical Care AG & Co KGaA ST | -0.430% | -4.796% | 0.310% | 1.446% | 3.238% | -11.967% | -38.172% |
| Universal Health Services B | 0.670% | 2.041% | 9.489% | 2.740% | -21.875% | 25.000% | 19.474% |
News
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
Key Points
- Interested in Fresenius Medical Care AG & Co. KGaA? Here are five stocks we like better.
- Fresenius Medical Care reported solid Q2 results, with organic revenue up 5% and operating
Quest Diagnostics Q2 Earnings Call Highlights
Key Points
- Interested in Quest Diagnostics Incorporated? Here are five stocks we like better.
- Quest Diagnostics posted strong Q2 results, with revenue up 10.2% to $3.04 billion and adjusted